Frequent Fallers' Experiences of an Adapted Walking Frame, Designed to Reduce the Walking Aid's Associated Falls Risk

Falls Injury Clinical Trial

— Walker  

Official title:

A Pilot Investigation Into Frequent Fallers' Experiences of an Adapted Walking Frame, Designed to Reduce the Walking Aid's Associated Falls Risk

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03419845
• Other study ID #: 216488
• Status: Completed
• Phase: N/A
• First received: February 20, 2017
• Last updated: January 26, 2018
• Start date: May 18, 2017
• Est. completion date: June 30, 2017

Study information

• Verified date: January 2018
• Source: Birmingham Community Healthcare NHS
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

For some patients with mobility issues, a walking frame (commonly known as a zimmer frame - trademark of Zimmer Holdings), is provided to keep them on their feet and help them remain more independent in their home and when out and about. When patients are given the walking frame, they are given information on how to use it safely to protect them from hurting themselves. For a small group of patients, using the walking frame is difficult, and they will have a fall because they are unable to use the frame safely. For these patients, a fear of falling can then develop and they can then have more falls. It is thought that these falls with the walking frame happen because the patient steps too far into the frame, making them unstable. We have made an attachment for a standard walking frame, which we are calling the Step Right Buddy, that we think will help improve the stability of patients who step too far into the frame. We have attached a detachable elasticated band across the back legs of the frame to make patients aware that they have stepped far enough into the frame, to stop them stepping any further. In order to develop this further, we need to understand how people feel using this adapted frame and whether there are any new risks to the user.

The investigators propose to ask patients who are considered to be at risk of falling because of the way they use their walking frame if they would like to use the adapted walking frame in their home, instead of their standard frame, for a week. At the end of this week, investigators will spend up to an hour with this patient, talking with them about their experience of the adapted walking frame, in order to understand things such as how they felt using the frame, were they more or less fearful of using it than their usual frame, did they think they were going to fall over more or less often, do they think they fall more or less often. In addition to this, patients will keep a written record of when they thought they nearly fell, or when they had an injury whilst using the adapted walking frame. This information will be used to explore whether or not the adaption to the frame introduces new risks to patients.

Description:

Title: A pilot investigation into frequent fallers' experiences of an adapted walking frame, designed to reduce the walking aid's associated falls risk.

Short title: The Walker Study

Chief Investigator: Dr Sarahjane Jones

Objectives:

To qualitatively explore the user's experience of the Step Right Buddy after a one week pilot trial and to assess the introduction of new risks to the patient as a result of the adaptation.

Trial configuration:

Qualitatively assessed clinical trial of a novel product.

Setting: Community care - patient homes.

Sample size: 20

Description of intervention: Application of the Step Right Buddy to the standard walking frame for patients to use as normal at home for one week.

Study duration:

Project length: March 2017 - July 2017

Length of participation - 1 week from consent

Randomisation and blinding: Single arm, open trial

Outcome measures: Participants' experiences of using the Step Right Buddy and adverse event data.

Analysis techniques: Framework analysis of textual data regarding the participants experiences and, where appropriate, root cause analysis of adverse events.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 17
• Est. completion date: June 30, 2017
• Est. primary completion date: June 30, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Purposively sampled as those identified as 'fallers' as a result of their use of the walking frame or at risk of falling currently on the case load of the rehabilitation team within Birmingham Community Healthcare NHS Trust

• Routinely use walking frame to manoeuvre around the house and/or outside

• 18 years old or greater (no upper age limit)

• Have no visual impairments

• Must have mental capacity to consent for themselves

• Must speak, read and comprehend English to participate in the interview

Exclusion Criteria:

• This are not perceived to be at risk of falling as a result of their use of the walking frame

• Are younger than 18 years of age

• Are visually impaired

• Do not have mental capacity to consent for themselves

• Cannot comprehend written and spoken English sufficiently to give informed consent

• Are unable to follow the safety instructions for using the Step Right Buddy

Related Conditions & MeSH terms

• Falls Injury

Intervention

Device:
• Step Right Buddy
The Step Right Buddy, which is under investigation in this clinical study, is an elasticated band that attached by Velcro to the back legs of a standard walking frame. The purpose of the Step Right Buddy is to provide sensory feedback to standard walking frame users of how far to step in to the frame and to encourage them to move the frame forward.

Locations

Country	Name	City	State
United Kingdom	Clive Thursfield	Birmingham	West Midlands

Sponsors (2)

Lead Sponsor	Collaborator
Birmingham Community Healthcare NHS	Birmingham City University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	User experience	User experience will be assessed by asking the patient to trial the attachment for one week, completing a risk form during this week and providing verbal feedback at the end of this week.	1 week
Secondary	Adverse events	To assess the introduction of new risks to the patient as a result of the adaptation	1 week